Therefore, this study aimed to investigate the role of intratumoral nerves in both the tumor progression and checkpoint blockade immunotherapy in OSCC, as well as explore the impact of TGFβ signaling in this cancer-neuro-immune communication, to provide evidence for targeting nerve-cancer cross-talk as a potential adjuvant therapeutic approach for OSCC control. The gene discussed is TGFB1; the disease is cancer.